Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) had Income from Continuous Operations of $-15.11M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-15.11M |
|
-- |
|
-- |
|
$15.53M |
|
$-15.53M |
|
$0.44M |
|
$-15.08M |
|
$-15.08M |
|
$-15.11M |
|
|
Income from Continuous Operations |
$-15.11M |
$-15.11M |
|
$-15.11M |
|
$-15.53M |
|
$-15.35M |
|
55.66M |
|
55.66M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$50.93M |
|
$3.81M |
|
$5.15M |
|
$56.08M |
|
$13.61M |
|
$0.37M |
|
$0.48M |
|
$14.10M |
|
$41.98M |
|
$41.94M |
|
$41.98M |
|
56.44M |
|
| Cash Flow Statement Financials | |
$-51.21M |
|
$9.82M |
|
$1.09M |
|
$78.23M |
|
$38.34M |
|
$-39.89M |
|
$3.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.74 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-51.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-35.99% |
|
-36.03% |
|
-26.94% |
|
-35.68% |
|
$0.74 |
|
$-0.93 |
|
$-0.92 |
|